| Issue Date | Title | Author(s) |
| 2021-09 | Revolutionizing polymer-based nanoparticle-linked vaccines for targeting respiratory viruses: A perspective | Chan, Y; Ng, SW; Singh, SK; Gulati, M; Gupta, G; Chaudhary, SK; Hing, GB; Collet, T; MacLoughlin, R; Löbenberg, R; Oliver, BG; Chellappan, DK; Dua, K |
| 2021-06 | Nuclear factor-kappa B and its role in inflammatory lung disease | Alharbi, KS; Fuloria, NK; Fuloria, S; Rahman, SB; Al-Malki, WH; Javed Shaikh, MA; Thangavelu, L; Singh, SK; Rama Raju, VS; Jha, NK; Chellappan, DK; Dua, K; Gupta, G |
| 2021-06 | Current trends on resveratrol bioactivities to treat periodontitis | Sharifi-Rad, J; Quispe, C; Alfred, MA; Anil Kumar, NV; Lombardi, N; Cinquanta, L; Iriti, M; Varoni, EM; Gupta, G; Chellappan, DK; Dua, K; Cardoso, SM; Peron, G; Dey, A; Cruz-Martins, N; Rodrigues, CF |
| - | An Appraisal of the Current Scenario in Vaccine Research for COVID-19 | Chong, WC; Chellappan, DK; Shukla, SD; Peterson, GM; Patel, RP; Jha, NK; Eri, RD; Dua, K; Tambuwala, MM; Shastri, MD |
| 2021-01 | Recent update on barbiturate in relation to brain disorder. | Pathak, S; Gupta, G; Thangavelu, L; Singh, SK; Dua, K; Chellappan, DK; Gilhotra, RM |
| - | Effects of curcumin-loaded poly(lactic-co-glycolic acid) nanoparticles in MDA-MB231 human breast cancer cells | Sharma, A; Hawthorne, S; Jha, SK; Jha, NK; Kumar, D; Girgis, S; Goswami, VK; Gupta, G; Singh, S; Dureja, H; Chellappan, DK; Dua, K |
| - | Harnessing the Potential of CRISPR/Cas in Atherosclerosis: Disease Modeling and Therapeutic Applications | Siew, WS; Tang, YQ; Kong, CK; Goh, B-H; Zacchigna, S; Dua, K; Chellappan, DK; Duangjai, A; Saokaew, S; Phisalprapa, P; Yap, WH |
| - | Advances in pulmonary drug delivery targeting microbial biofilms in respiratory diseases | Sharma, A; Kumar, D; Dahiya, K; Hawthorne, S; Jha, SK; Jha, NK; Nand, P; Girgis, S; Raj, S; Srivastava, R; Goswami, VK; Gregoriou, Y; El-Zahaby, SA; Ojha, S; Dureja, H; Gupta, G; Singh, S; Chellappan, DK; Dua, K |
| - | Emerging cases of mucormycosis under COVID ‐19 pandemic in India: Misuse of antibiotics | Gupta, G; S., R; Singh, Y; Thangavelu, L; Singh, SK; Dureja, H; Chellappan, DK; Dua, K |
| - | Emerging cases of mucormycosis under COVID ‐19 pandemic in India: Misuse of antibiotics | Gupta, G; S., R; Singh, Y; Thangavelu, L; Singh, SK; Dureja, H; Chellappan, DK; Dua, K |
